Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophia Jeschke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Anticancer Research|April 19, 2006
Chemotherapy treatment options for elderly women with breast cancerSherko Kümmel, Dirk Elling, Sophia Jeschke, et al.
Anticancer Research|April 19, 2006
Postoperative therapy modalities for cervical carcinomaSherko Kümmel, Anke Thomas, Sophia Jeschke, et al.
Anticancer Research|July 23, 2011
Prognostic significance of angiogenic factors in uterine cervical cancerSolveig Landt, Michael Wehling, Harald Heidecke, et al.
Anticancer Research|March 25, 2010
Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancerSolveig Landt, Sophia Jeschke, Angela Koeninger, et al.
Anticancer Research|April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodesSherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Anticancer Research|April 19, 2006
Chemotherapy treatment options for elderly women with breast cancerSherko Kümmel, Dirk Elling, Sophia Jeschke, et al.
Anticancer Research|April 19, 2006
Postoperative therapy modalities for cervical carcinomaSherko Kümmel, Anke Thomas, Sophia Jeschke, et al.
Anticancer Research|July 23, 2011
Prognostic significance of angiogenic factors in uterine cervical cancerSolveig Landt, Michael Wehling, Harald Heidecke, et al.
Anticancer Research|March 25, 2010
Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancerSolveig Landt, Sophia Jeschke, Angela Koeninger, et al.
Anticancer Research|April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodesSherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Pageof 1